Page last updated: 2024-08-18

allylamine and Hypercholesterolemia

allylamine has been researched along with Hypercholesterolemia in 50 studies

Research

Studies (50)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (6.00)	18.2507
2000's	30 (60.00)	29.6817
2010's	16 (32.00)	24.3611
2020's	1 (2.00)	2.80

Authors

Authors	Studies
Esan, O; Viljoen, A; Wierzbicki, AS	1
Jialal, I; Sheely, D	1
Bloks, VW; Boverhof, R; de Boer, RA; Groen, AK; Havinga, R; Kuipers, F; Meissner, M; Wolters, H	1
Ishisaka, DY; Jukes, T; Leahy, A; Qian, C; Romanelli, RJ; Ye, X	1
Ishisaka, DY; Jukes, T; Kang, A; Leahy, A; Romanelli, RJ; Ye, X	1
Dayer-Berenson, L; Finckenor, M	1
Brønden, A; Hansen, M; Knop, FK; Rohde, U; Sonne, DP; Vilsbøll, T	1
Bays, H; Li, Y; Louder, A; Mallick, R; Schwab, P	1
Fonseca, VA; Goldberg, RB; Jones, MR; Truitt, KE	1
Corsini, A; Farnier, M; Windler, E	1
Handelsman, Y	2
Fonseca, VA; Goldfine, AB	1
Staels, B	1
Hagan, MA; Simons, WR	1
Lee, T	1
Davidson, MH; Donovan, JM; Jones, MR; Misir, S	1
Avitabile, N; Banka, A; Fonseca, VA	1
Brunetti, L; Campbell, RK	1
Aggarwal, S; Arora, RR; Loomba, RS	1
Elisaf, MS; Florentin, M; Kei, AA; Kostapanos, MS; Liamis, G; Liberopoulos, EN; Rizos, CV	1
Athyros, VG; Karagiannis, A; Mikhailidis, DP; Tziomalos, K	1
Bretz, F; Hothorn, LA; Hsu, JC	1
Bays, H; Dujovne, C	1
Melian, EB; Plosker, GL	1
Farmer, JA; Manhas, A	1
Ballantyne, CM; Chiou, P; Guyton, JR; Jones, PH; Stein, JL; Xydakis, AM	1
Larsen, ML; Raungaard, B	1
Rosenson, RS	1
Burke, SK; Donovan, JM; Illingworth, DR; Isaacsohn, J; Olson, T; Pappu, AS; Setchell, KD; Von Bergmann, K	1
Abby, SL; Bays, HE; Davidson, M; Jones, MR	1
Autret, B; Devaraj, S; Jialal, I	1
Abby, S; Bays, H; Jones, M; Lai, YL; Rhyne, J	1
Anderson, S; Fish, B; Knopp, RH; Nguyen, H; Nguyen, T; Retzlaff, BM; Tsunehara, C	1
Keating, GM; Robinson, DM	1
Goldberg, DJ; Nicolosi, RJ; Rogers, EJ; Sacchiero, R; Wilson, TA	1
Burke, SK; Davidson, MH; Dillon, MA; Gordon, B; Isaacsohn, J; Jones, P; Samuels, J; Toth, P; Weiss, S	1
Henney, JE	1
Burke, SK; Chin, B; Davidson, MH; Donovan, JM; Gaziano, JM; Knapp, HH; Knopp, R; Ma, P; Schrott, H	1
Burke, SK; Davidson, MH; Donovan, JM; Hunninghake, D; Isaacsohn, J; McKenney, J; Toth, P; Weiss, S	1
Burke, SK; Davidson, D; Donovan, JM; Hunninghake, D; Insull, W; Toth, P	1
Burke, S; Davidson, MH; Donovan, JM; Hunninghake, D; Insull, W; Mullican, W; Toth, P	1
Steinmetz, KL	1

Reviews

16 review(s) available for allylamine and Hypercholesterolemia

Article	Year
Expanded colesevelam administration options with oral suspension formulation for patients with diabetes and hypercholesterolemia. Postgraduate medicine, 2014, Volume: 126, Issue:3 Topics: Allylamine; Anticholesteremic Agents; Blood Glucose; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypercholesterolemia; Lipids; Suspensions; Tablets	2014
Sevelamer in a diabetologist's perspective: a phosphate-binding resin with glucose-lowering potential. Diabetes, obesity & metabolism, 2015, Volume: 17, Issue:2 Topics: Allylamine; Anticholesteremic Agents; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypercholesterolemia; Hypoglycemic Agents; Polyamines; Sevelamer; Treatment Outcome; Triglycerides	2015
Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol. European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology, 2009, Volume: 16, Issue:1 Topics: Allylamine; Anticholesteremic Agents; Cholesterol, LDL; Colesevelam Hydrochloride; Drug Interactions; Humans; Hypercholesterolemia	2009
The use of colesevelam HCl in patients with type 2 diabetes mellitus: combining glucose- and lipid-lowering effects. Postgraduate medicine, 2009, Volume: 121, Issue:3 Suppl 1 Topics: Allylamine; Anticholesteremic Agents; Bile Acids and Salts; Blood Glucose; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypercholesterolemia; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; United States	2009
The role of colesevelam HCl in type 2 diabetes mellitus therapy. Postgraduate medicine, 2009, Volume: 121, Issue:3 Suppl 1 Topics: Allylamine; Anticholesteremic Agents; Blood Glucose; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypercholesterolemia; Life Style; Patient Education as Topic; Primary Prevention; United States	2009
A review of bile acid sequestrants: potential mechanism(s) for glucose-lowering effects in type 2 diabetes mellitus. Postgraduate medicine, 2009, Volume: 121, Issue:3 Suppl 1 Topics: Allylamine; Animals; Anticholesteremic Agents; Bile Acids and Salts; Blood Glucose; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypercholesterolemia; United States	2009
Safety evaluation of colesevelam therapy to achieve glycemic and lipid goals in type 2 diabetes. Expert opinion on drug safety, 2011, Volume: 10, Issue:2 Topics: Adult; Allylamine; Animals; Anticholesteremic Agents; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Randomized Controlled Trials as Topic	2011
Clinical efficacy of colesevelam in type 2 diabetes mellitus. Journal of pharmacy practice, 2011, Volume: 24, Issue:4 Topics: Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Humans; Hypercholesterolemia; Randomized Controlled Trials as Topic	2011
Efficacy of colesevelam on lowering glycemia and lipids. Journal of cardiovascular pharmacology, 2012, Volume: 59, Issue:2 Topics: Allylamine; Animals; Anticholesteremic Agents; Blood Glucose; Cholesterol; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypercholesterolemia; Triglycerides	2012
Colesevelam: a new and improved bile acid sequestrant? Current pharmaceutical design, 2013, Volume: 19, Issue:17 Topics: Allylamine; Anticholesteremic Agents; Bile Acids and Salts; C-Reactive Protein; Cholesterol, LDL; Clinical Trials as Topic; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Drug Interactions; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia	2013
Colesevelam HCl: a non-systemic lipid-altering drug. Expert opinion on pharmacotherapy, 2003, Volume: 4, Issue:5 Topics: Allylamine; Animals; Child; Clinical Trials as Topic; Colesevelam Hydrochloride; Drug Interactions; Female; Half-Life; Humans; Hypercholesterolemia; Hypolipidemic Agents	2003
Colesevelam. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2001, Volume: 1, Issue:2 Topics: Allylamine; Clinical Trials as Topic; Colesevelam Hydrochloride; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hypolipidemic Agents	2001
Hypolipidemic therapy and cholesterol absorption. Current atherosclerosis reports, 2004, Volume: 6, Issue:2 Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cholesterol; Colesevelam Hydrochloride; Ezetimibe; Humans; Hypercholesterolemia; Intestinal Absorption	2004
Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia. The American journal of cardiology, 2006, Apr-15, Volume: 97, Issue:8 Topics: Allylamine; C-Reactive Protein; Cholagogues and Choleretics; Cholesterol; Cholesterol, LDL; Colesevelam Hydrochloride; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic	2006
Colesevelam: a review of its use in hypercholesterolemia. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2007, Volume: 7, Issue:6 Topics: Allylamine; Anticholesteremic Agents; Cholesterol, LDL; Colesevelam Hydrochloride; Drug Therapy, Combination; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents	2007
Colesevelam hydrochloride. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2002, May-15, Volume: 59, Issue:10 Topics: Allylamine; Cholestyramine Resin; Colesevelam Hydrochloride; Colestipol; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hypolipidemic Agents	2002

Trials

14 trial(s) available for allylamine and Hypercholesterolemia

Article	Year
Colesevelam in the treatment of hypercholesterolemia and hyperglycemia: a retrospective analysis from an ambulatory care medical network. Current medical research and opinion, 2013, Volume: 29, Issue:12 Topics: Adolescent; Adult; Aged; Allylamine; Ambulatory Care; Anticholesteremic Agents; California; Cholesterol, LDL; Colesevelam Hydrochloride; Female; Humans; Hypercholesterolemia; Hyperglycemia; Male; Middle Aged; Retrospective Studies	2013
Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy. Archives of internal medicine, 2008, Jul-28, Volume: 168, Issue:14 Topics: Adolescent; Adult; Aged; Allylamine; Anticholesteremic Agents; Blood Glucose; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hypoglycemic Agents; Insulin; Male; Mexico; Middle Aged; Prospective Studies; Treatment Outcome; United States	2008
A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2010, Volume: 10, Issue:5 Topics: Adult; Aged; Alanine Transaminase; Allylamine; Anticholesteremic Agents; Aspartate Aminotransferases; Cholesterol, HDL; Cholesterol, LDL; Colesevelam Hydrochloride; Double-Blind Method; Female; Humans; Hypercholesterolemia; Male; Middle Aged	2010
Colesevelam plus rosuvastatin 5 mg/day versus rosuvastatin 10 mg/day alone on markers of insulin resistance in patients with hypercholesterolemia and impaired fasting glucose. Metabolic syndrome and related disorders, 2013, Volume: 11, Issue:3 Topics: Aged; Allylamine; Anticholesteremic Agents; Biomarkers; Blood Glucose; Colesevelam Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Fasting; Female; Fluorobenzenes; Glucose Intolerance; Humans; Hypercholesterolemia; Insulin Resistance; Male; Middle Aged; Prediabetic State; Pyrimidines; Rosuvastatin Calcium; Sulfonamides	2013
Colesevelam HCl reduces LDL particle number and increases LDL size in hypercholesterolemia. Atherosclerosis, 2006, Volume: 185, Issue:2 Topics: Allylamine; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Colesevelam Hydrochloride; Double-Blind Method; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Particle Size; Triglycerides	2006
Effects of colesevelam HC1 on sterol and bile acid excretion in patients with type IIa hypercholesterolemia. Digestive diseases and sciences, 2005, Volume: 50, Issue:7 Topics: Allylamine; Bile Acids and Salts; Cholesterol; Cholesterol, LDL; Colesevelam Hydrochloride; Dose-Response Relationship, Drug; Feces; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Sterols; Treatment Outcome	2005
Effects of colesevelam hydrochloride (WelChol) on biomarkers of inflammation in patients with mild hypercholesterolemia. The American journal of cardiology, 2006, Sep-01, Volume: 98, Issue:5 Topics: Adult; Allylamine; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Colesevelam Hydrochloride; Double-Blind Method; Follow-Up Studies; Humans; Hypercholesterolemia; Inflammation; Treatment Outcome	2006
Lipid-lowering effects of colesevelam HCl in combination with ezetimibe. Current medical research and opinion, 2006, Volume: 22, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Allylamine; Apolipoprotein A-I; Apolipoproteins B; Azetidines; Cholesterol; Colesevelam Hydrochloride; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Patient Compliance; Treatment Outcome	2006
Lipoprotein effects of combined ezetimibe and colesevelam hydrochloride versus ezetimibe alone in hypercholesterolemic subjects: a pilot study. Metabolism: clinical and experimental, 2006, Volume: 55, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Allylamine; Anticholesteremic Agents; Azetidines; Cholesterol, HDL; Cholesterol, LDL; Colesevelam Hydrochloride; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Pilot Projects; Triglycerides	2006
Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects. Archives of internal medicine, 1999, Sep-13, Volume: 159, Issue:16 Topics: Adult; Aged; Allylamine; Bile Acids and Salts; Cholagogues and Choleretics; Cholesterol, HDL; Cholesterol, LDL; Colesevelam Hydrochloride; Digestive System; Double-Blind Method; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; Lipids; Male; Middle Aged; Triglycerides	1999
Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia. The American journal of medicine, 2001, Apr-01, Volume: 110, Issue:5 Topics: Adult; Aged; Allylamine; Analysis of Variance; Anticholesteremic Agents; Apolipoproteins; Cholagogues and Choleretics; Cholesterol, HDL; Cholesterol, LDL; Colesevelam Hydrochloride; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Male; Middle Aged; Simvastatin; Treatment Outcome; Triglycerides	2001
Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia. Clinical cardiology, 2001, Volume: 24, Issue:6 Topics: Allylamine; Analysis of Variance; Anticholesteremic Agents; Cholesterol, LDL; Colesevelam Hydrochloride; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Treatment Outcome	2001
Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively. Atherosclerosis, 2001, Volume: 158, Issue:2 Topics: Adult; Aged; Allylamine; Anticholesteremic Agents; Atorvastatin; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Colesevelam Hydrochloride; Double-Blind Method; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Pyrroles; Triglycerides	2001
Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial. Mayo Clinic proceedings, 2001, Volume: 76, Issue:10 Topics: Adult; Aged; Allylamine; Analysis of Variance; Anticholesteremic Agents; Apolipoproteins B; Cholesterol, LDL; Colesevelam Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Statistics, Nonparametric; Treatment Outcome	2001

Other Studies

20 other study(ies) available for allylamine and Hypercholesterolemia

Article	Year
Colesevelam - a bile acid sequestrant for treating hypercholesterolemia and improving hyperglycemia. Expert opinion on pharmacotherapy, 2022, Volume: 23, Issue:12 Topics: Allylamine; Anticholesteremic Agents; Bile Acids and Salts; Cardiovascular Diseases; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperglycemia; Hyperlipidemias; Hypolipidemic Agents; Triglycerides	2022
Strategies to lower low-density lipoprotein cholesterol in metabolic syndrome: averting the diabetes risk. Metabolic syndrome and related disorders, 2013, Volume: 11, Issue:3 Topics: Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Female; Fluorobenzenes; Glucose Intolerance; Humans; Hypercholesterolemia; Insulin Resistance; Male; Pyrimidines; Rosuvastatin Calcium; Sulfonamides	2013
Bile acid sequestration normalizes plasma cholesterol and reduces atherosclerosis in hypercholesterolemic mice. No additional effect of physical activity. Atherosclerosis, 2013, Volume: 228, Issue:1 Topics: Allylamine; Animal Feed; Animals; Anticholesteremic Agents; Aorta; Atherosclerosis; Bile Acids and Salts; Cardiac Output; Cholesterol; Colesevelam Hydrochloride; Echocardiography; Feces; Hypercholesterolemia; Liver; Male; Mice; Mice, Knockout; Physical Conditioning, Animal; Receptors, LDL; Sterols	2013
Multivariate analysis of factors associated with persistent colesevelam treatment among patients with hypercholesterolemia. The Annals of pharmacotherapy, 2013, Volume: 47, Issue:10 Topics: Adolescent; Adult; Aged; Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Multivariate Analysis; Treatment Outcome; Young Adult	2013
Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe. Drugs & aging, 2014, Volume: 31, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allylamine; Anticholesteremic Agents; Azetidines; Cohort Studies; Colesevelam Hydrochloride; Coronary Artery Disease; Diagnosis-Related Groups; Ezetimibe; Female; Health Services for the Aged; Humans; Hypercholesterolemia; Male; Middle Aged; Retrospective Studies; Treatment Outcome; United States	2014
What role for [black triangle down] colesevelam in cardiovascular prevention? Drug and therapeutics bulletin, 2009, Volume: 47, Issue:5 Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Colesevelam Hydrochloride; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Treatment Outcome	2009
The use of the bile acid sequestrant colesevelam HCl in patients with type 2 diabetes mellitus: for glucose and lipid control. Introduction. Postgraduate medicine, 2009, Volume: 121, Issue:3 Suppl 1 Topics: Allylamine; Anticholesteremic Agents; Bile Acids and Salts; Blood Glucose; Centers for Disease Control and Prevention, U.S.; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypercholesterolemia; United States	2009
An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus. PharmacoEconomics, 2010, Volume: 28, Issue:9 Topics: Adult; Aged; Allylamine; Cardiovascular Diseases; Cholesterol, LDL; Colesevelam Hydrochloride; Cost-Benefit Analysis; Databases, Factual; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Health Care Costs; Humans; Hypercholesterolemia; Insulin; Male; Metformin; Middle Aged; Models, Economic; Randomized Controlled Trials as Topic; Risk; Sulfonylurea Compounds; Treatment Outcome; United States	2010
Ask the doctor. I have tried all of the statin drugs to lower my cholesterol, but each one has caused severe muscle pain. Are there any non-statin medications I could try using to lower my cholesterol? Harvard heart letter : from Harvard Medical School, 2010, Volume: 20, Issue:12 Topics: Allylamine; Azetidines; Colesevelam Hydrochloride; Diet, Mediterranean; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Muscular Diseases; Niacin; Pain; Sitosterols	2010
[Hypercholesterolemia: when statins are not enough or not tolerated. With combination therapy to LDL cholesterol target goal]. MMW Fortschritte der Medizin, 2012, Jul-26, Volume: 154, Issue:13 Topics: Allylamine; Anticholesteremic Agents; Cholesterol, LDL; Colesevelam Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Randomized Controlled Trials as Topic	2012
Identifying effective and/or safe doses by stepwise confidence intervals for ratios. Statistics in medicine, 2003, Mar-30, Volume: 22, Issue:6 Topics: Allylamine; Anticholesteremic Agents; Cholesterol, LDL; Clinical Trials, Phase III as Topic; Colesevelam Hydrochloride; Confidence Intervals; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hypercholesterolemia; Numerical Analysis, Computer-Assisted; Research Design; Simvastatin	2003
Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia. The American journal of cardiology, 2004, Sep-15, Volume: 94, Issue:6 Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cholestyramine Resin; Colesevelam Hydrochloride; Colestipol; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Prospective Studies; Treatment Outcome	2004
[Colesevelam hydrochloride. A product description]. Ugeskrift for laeger, 2005, Mar-14, Volume: 167, Issue:11 Topics: Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Drug Therapy, Combination; Humans; Hypercholesterolemia	2005
Lower cholesterol without statins. Options are available. Mayo Clinic health letter (English ed.), 2006, Volume: 24, Issue:5 Topics: Allylamine; Azetidines; Cholesterol, LDL; Cholinergic Antagonists; Colesevelam Hydrochloride; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Phytosterols	2006
Studies of cholesterol and bile acid metabolism, and early atherogenesis in hamsters fed GT16-239, a novel bile acid sequestrant (BAS). Atherosclerosis, 1998, Volume: 140, Issue:2 Topics: Allylamine; Animals; Anticholesteremic Agents; Aortic Diseases; Arteriosclerosis; Aryl Hydrocarbon Hydroxylases; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Cricetinae; Cytochrome P-450 Enzyme System; Feces; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Lipoproteins; Liver; Male; Mesocricetus; Polyamines; Steroid Hydroxylases	1998
Colesevelam. GT 31104, CholestaGel. Drugs in R&D, 1999, Volume: 1, Issue:6 Topics: Allylamine; Anticholesteremic Agents; Cholesterol, LDL; Colesevelam Hydrochloride; Drugs, Investigational; Humans; Hypercholesterolemia	1999
From the Food and Drug Administration. JAMA, 2000, Aug-09, Volume: 284, Issue:6 Topics: Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Hydrogels; Hypercholesterolemia; Lung Neoplasms; Surgical Equipment; United States; United States Food and Drug Administration	2000
Colesevelam (Welchol) for hypercholesterolemia. The Medical letter on drugs and therapeutics, 2000, Oct-30, Volume: 42, Issue:1091 Topics: Allylamine; Anticholesteremic Agents; Cholesterol, LDL; Colesevelam Hydrochloride; Digestive System; Drug Interactions; Humans; Hypercholesterolemia; Intestinal Absorption; Randomized Controlled Trials as Topic	2000
New cholesterol-lowering drug is now available. Mayo Clinic health letter (English ed.), 2001, Volume: 19, Issue:2 Topics: Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Humans; Hypercholesterolemia	2001
Colesevelam hydrochloride. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2002, Feb-01, Volume: 59, Issue:3 Topics: Allylamine; Clinical Trials as Topic; Colesevelam Hydrochloride; Digestive System; Drug Interactions; Drug Labeling; Humans; Hypercholesterolemia; Hypolipidemic Agents	2002